Management of Sciatica

Pharmacological Management

NSAIDs are strongly recommended as initial pharmacological management, with maximum tolerated dosage and evaluation of response after 2-4 weeks, by the American College of Rheumatology and the European League Against Rheumatism, with moderate-quality evidence showing they are slightly more effective than placebo for short-term pain reduction and disability improvement 1, 2, 3, 4
For pain control when NSAIDs are insufficient, contraindicated, or poorly tolerated, paracetamol and opioids (short-term use) may be considered, as recommended by the European League Against Rheumatism 5
Gabapentin may be considered for neuropathic pain components of sciatica, although the evidence is limited, as noted by the American College of Physicians and the American College of Rheumatology 3, 4, 6

Long-term use of systemic glucocorticoids is strongly recommended against, according to the American College of Rheumatology, the American College of Physicians, the Annals of the Rheumatic Diseases, and the National Osteoporosis Foundation, due to an unfavorable risk-benefit profile and increased risk of serious adverse effects without evidence of sustained benefit 1, 4, 2, 3, 7
Oral steroids are not recommended due to lack of evidence for benefit and potential for harm in patients with non-radicular low back pain, as stated by the American College of Physicians guideline, with moderate-quality evidence showing no benefit for acute non-radicular low back pain, and may only be considered in very specific circumstances, such as a short-term bridging option (maximum 15 days), with careful monitoring for adverse effects 4, 2, 3, 8, 7
Short courses of oral prednisone significantly increase the risk of adverse events, including insomnia, nervousness, increased appetite, and potential for hyperglycemia, as reported by the Annals of Internal Medicine and Arthritis and Rheumatology 2, 7, 2

Injections should be performed in experienced centers, preferably with imaging guidance, as recommended by the American College of Rheumatology, and may include local corticosteroid injections directed to specific sites of inflammation, which may be more effective than systemic administration, although the evidence is not strongly supported by high-quality trials 1, 2
Epidural steroid injections may be considered for short-term relief when other options fail, with moderate-quality evidence showing they are probably more effective than placebo for short-term leg pain reduction and short-term disability reduction, but offer no significant functional benefit or reduction in surgery rates, as noted by the American Academy of Neurology 3, 8, 3
Injections around Achilles, patellar, and quadriceps tendons should be avoided due to the risk of tendon rupture, as recommended by Arthritis and Rheumatology 8

Patients with sciatica should maintain physical activity, apply local heat, consider physiotherapy, and receive patient education on the natural history of the condition, as recommended by the American College of Physicians and the American College of Rheumatology 2, 3, 4, 6
Special consideration is required for patients with spinal bone lesions with risk of vertebral collapse, including the use of bisphosphonates or other osteoporosis treatments, as recommended by the National Osteoporosis Foundation 3
Patients presenting with significant accumulated skeletal damage may benefit from disease-modifying antirheumatic drugs (DMARDs) or other treatments aimed at reducing disease progression, according to the American College of Rheumatology 3
For isolated active sacroiliitis, locally administered parenteral glucocorticoids are conditionally recommended over no treatment, as suggested by Arthritis and Rheumatology 8